PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $20,095,442,000 | +100593.7% | 3,948,024 | 0.0% | 0.13% | -3.6% |
| Q3 2019 | $19,957,000 | -18.1% | 3,948,024 | 0.0% | 0.14% | -16.8% |
| Q2 2019 | $24,359,000 | +33.0% | 3,948,024 | 0.0% | 0.17% | +28.5% |
| Q1 2019 | $18,318,000 | +10.5% | 3,948,024 | 0.0% | 0.13% | -7.1% |
| Q4 2018 | $16,582,000 | -33.0% | 3,948,024 | 0.0% | 0.14% | -20.9% |
| Q3 2018 | $24,745,000 | -22.0% | 3,948,024 | 0.0% | 0.18% | -29.2% |
| Q2 2018 | $31,742,000 | +13.1% | 3,948,024 | 0.0% | 0.25% | +14.7% |
| Q1 2018 | $28,070,000 | +28.8% | 3,948,024 | +7.8% | 0.22% | -6.0% |
| Q4 2017 | $21,790,000 | – | 3,662,118 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Phocas Financial Corp. | 1,033,328 | $6,376,000 | 0.68% |
| ARDSLEY ADVISORY PARTNERS LP | 650,000 | $4,011,000 | 0.63% |
| Worth Venture Partners, LLC | 138,357 | $853,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,242,503 | $13,836,000 | 0.46% |
| HIGHLAND CAPITAL MANAGEMENT LP | 716,880 | $4,423,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,543,386 | $34,203,000 | 0.22% |
| Point72 Asset Management, L.P. | 5,858,749 | $36,148,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 1,298,723 | $8,013,000 | 0.19% |
| Fosun International Ltd | 472,580 | $2,750,000 | 0.18% |
| J. Goldman & Co LP | 400,000 | $2,468,000 | 0.17% |